Fundz

Geron Corporation secures up to $375 million in debt financing led by Royalty Pharma and Pharmakon Advisors to support the commercial launch of RYTELO and complete Phase 3 clinical trials.

PUBLIC · GERNNov 07, 2024

Amount Raised

$375 Million

Round Type

Debt Financing

Foster CityBiotechnologyHealth Careresearch

Investors

Royalty PharmaPharmakon Advisors

Description

Geron Corporation has announced up to $375 million in synthetic royalty and debt financings with Royalty Pharma and investment funds managed by Pharmakon Advisors. The funding includes $250 million in cash and an additional $125 million in debt to facilitate the commercial launch of RYTELO and to address working capital requirements.

Quick answer

Geron raised $375 Million in a Debt Financing round, dated November 7, 2024. Investors: Royalty Pharma and Pharmakon Advisors. Geron is based in Foster City, California, United States.

How much did Geron raise?
Geron raised $375 Million in a Debt Financing round on November 7, 2024.
Who invested in Geron?
Royalty Pharma and Pharmakon Advisors are named as investors in this round.
What does Geron do?
Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer.
Where is Geron based and how big is it?
Geron is based in Foster City, California, United States. Fundz records about 230 employees.
Who are the decision-makers at Geron?
Fundz holds 1 contact at Geron, including the Interim President and Chief Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as Geron that raised within 45 days of this round, from Fundz verified event records.

  • Nuvig Therapeutics raised $161M (Series B) on December 5, 2024.
  • FOXO Technologies raised $220K on November 15, 2024.
  • Aarvik Therapeutics raised $1.2M (Seed) on November 4, 2024.
  • Gameto raised $10M (Funding Round) on October 24, 2024.
  • FOXO Technologies raised $257K on October 17, 2024.
  • FOXO Technologies raised $41K on October 17, 2024.

Who to call at Geron, and when

A new round usually means Geron is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Geron raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Geron, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Geron. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Geron

Location

919 E Hillsdale Blvd

Foster City, California, United States

About

Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor RYTELO® (imetelstat) is approved in the United States and the European Union for the treatment of certain adult patients with lower-risk myelodysplastic syndromes with transfusion dependent anemia. We are also conducting a pivotal Phase 3 clinical trial of imetelstat in JAK-inhibitor relapsed/refractory myelofibrosis, as well as studies in other myeloid hematologic malignancies. Inhibiting telomerase activity, which is increased in malignant stem and progenitor cells in the bone marrow, aims to reduce proliferation and induce death of malignant cells.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Geron raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsDawn B., Interim President and Chief Executive O…See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Geron's next move

See what Strategic adds

Geron raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.